By monitoring serial changes in an individual’s CA125 levels over time, ROCA demonstrated an increased cancer detection rate compared to a simple single-threshold rule in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [13]. Here, MUC16 is linked to ovarian carcinoma.